Stocks
GlaxoSmithKline (GSK) Net debt US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net debt, £ | 13 110 000 000 | 13 110 000 000 | 13 110 000 000 | 12 836 000 000 | 12 330 000 000 | -3 212 000 000 | |||
| Changes by years, y/y, % | -34% | 0% | 0% | -2% | -4% | -11.0% | |||
GlaxoSmithKline. Net debt, £
GlaxoSmithKline. Net debt, changes, %
GlaxoSmithKline (GSK) Net debt US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net debt, £ | 13 960 000 000 | 13 677 000 000 | -3 212 000 000 | 13 960 000 000 | -3 212 000 000 | -3 212 000 000 | ||
| Changes by years, y/y, % | -7% | -2% | -123% | -7% | -123% | |||
| Changes by quarters, q/q, % | +9% | -2% | -123% | -535% | -123% | |||
